Methylphenidate Hydrochloride Tablet, Extended Release — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Methylphenidate Hydrochloride Tablet, Extended Release (tablet) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Jul 26, 2023.

Shortage details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
62037-725-01
Dosage Form
Tablet
Presentation
Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01)
Initial Posting
Jul 26, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.